XDx's AlloMap[R] Recommended for Non-Invasive Monitoring of Acute Cellular Rejection in New ISHLT Guidelines for the Care of Heart Transplant Recipients
In: Biotech Week, 2010-08-25
Zeitungsartikel
Zugriff:
XDx, Inc., a molecular diagnostics company focused on non-invasive gene expression tests for the monitoring of immune-mediated conditions, announced the inclusion of the AlloMap® test in the inaugural published 'International [...]
Titel: |
XDx's AlloMap[R] Recommended for Non-Invasive Monitoring of Acute Cellular Rejection in New ISHLT Guidelines for the Care of Heart Transplant Recipients
|
---|---|
Zeitschrift: | Biotech Week, 2010-08-25 |
Veröffentlichung: | 2010 |
Medientyp: | Zeitungsartikel |
ISSN: | 1535-2757 (print) |
Schlagwort: |
|
Sonstiges: |
|